The Melatonin market has displayed contrasting regional trends in the first half of July 2025. While Asia-Pacific experienced a decline led by oversupply and weak procurement activity, North America maintained pricing stability due to controlled production and steady inventory consumption. China’s uninterrupted output and low global demand pressured its export market, prompting India to follow with sharper price adjustments to retain competitiveness. In contrast, the U.S. market demonstrated strategic supply alignment with downstream pharmaceutical and nutraceutical demand, avoiding disruptions and sustaining a balanced market environment.
